- Exchange: NASDAQ GS
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Therapeutics
Synageva BioPharma Corp+ Add to Watchlist
GEVA:US40.8800 USD 0.2900 0.71%
As of 20:10:00 ET on 05/24/2013.
Company Profile for Synageva BioPharma Corp (GEVA)
Synageva BioPharma Corp. is a clinical stage biopharmaceutical company. The Company is focused on the discovery, development, and commercialization of therapeutic products for patients with life-threatening rare diseases and unmet medical need.
Synageva BioPharma Corp
Key Executives for Synageva BioPharma Corp (GEVA)
|Sanj K PatelPresident/CEO/Secretary||Carsten BoessSenior VP/CFO|
|Anthony G QuinnSenior VP/Chief Medical Offcr||Marc E GoldbergSenior VP:Product Dev|
|Glen WilliamsSenior VP:Global Technical Ops|